Tag: cerebrospinal fluid

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

This 2010 guideline by the European Federation of Neurological Societies (EFNS) offers evidence-based recommendations for diagnosing and managing European Lyme neuroborreliosis (LNB). It emphasizes clinical assessment supported by cerebrospinal fluid (CSF) analysis, including pleocytosis and intrathecal Borrelia-specific antibody production. The guidelines recommend intravenous ceftriaxone (2 g/day for 14 days) as

Read More »

Lyme Neuroborreliosis

This 2019 review article provides a comprehensive overview of Lyme neuroborreliosis (LNB), a neurological complication of Lyme disease caused by the Borrelia burgdorferi sensu lato complex. LNB manifests in various forms, including meningitis, cranial neuritis (e.g., facial palsy), radiculoneuritis, and, in rare cases, encephalitis. The article discusses the pathogenesis involving

Read More »

Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men

The study “Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men” examined the effects of induced hypogonadism on sexual function and its relationship with cerebrospinal fluid (CSF) levels of neurosteroids and monoamine metabolites. In this comparative study, healthy male volunteers received the gonadotropin-releasing hormone agonist leuprolide acetate

Read More »